Kodiak Sciences (KOD) Gains from Sales and Divestitures (2017 - 2025)

Kodiak Sciences filings provide 8 years of Gains from Sales and Divestitures readings, the most recent being $45190.0 for Q4 2025.

  • Quarterly Gains from Sales and Divestitures fell 47.79% to $45190.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45190.0 through Dec 2025, down 47.79% year-over-year, with the annual reading at $45190.0 for FY2025, 47.79% down from the prior year.
  • Gains from Sales and Divestitures hit $45190.0 in Q4 2025 for Kodiak Sciences, up from $4869.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $116403.0 in Q4 2023 and bottomed at $3532.0 in Q1 2025.
  • Average Gains from Sales and Divestitures over 5 years is $56057.9, with a median of $70988.0 recorded in 2024.
  • The largest annual shift saw Gains from Sales and Divestitures surged 214.57% in 2022 before it plummeted 93.86% in 2025.
  • Kodiak Sciences' Gains from Sales and Divestitures stood at $93218.0 in 2021, then rose by 10.53% to $103032.0 in 2022, then rose by 12.98% to $116403.0 in 2023, then decreased by 25.64% to $86559.0 in 2024, then plummeted by 47.79% to $45190.0 in 2025.
  • Per Business Quant, the three most recent readings for KOD's Gains from Sales and Divestitures are $45190.0 (Q4 2025), $4869.0 (Q3 2025), and $29593.0 (Q2 2025).